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Thyroid hormone has a unique function in human organs. Many of its effects occur at the
level of gene expression and are mediated by thyroid hormone receptors (TRs). We
investigated the relationship between TRs and the prognosis of meningiomas. We
investigated TR expression in human intracranial meningiomas using reverse transcription-
polymerase chain reaction. Specimens of 25 tumors were obtained by craniotomy from
various intracranial meningiomas. We found that the expression of TRs was receptor
subtype- and cell type-dependent. Human TRα1 (hTRα1) was expressed in nine cases, hTRα2
was expressed in 14 cases, and both hTRα1 and hTRα2 were expressed in five cases; hTRβ1
was expressed in nine cases of recurrent or malignant tumors. The expression of hTRβ1 may
be an indicator of recurrent or malignant meningiomas.
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Modern microsurgical techniques have made it
possible to totally remove human intracranial
meningiomas. Recent advances in neuroimaging
studies, histopathology, and molecular biology have
great ly  improved our understanding of  the
pathophysiology of human meningiomas. We
investigated the relationship between thyroid hormone
receptors (TRs) and the prognosis of intracranial
meningiomas.
Thyroid hormone has a unique function in human
o r g a n s ,  r e g u l a t i n g  g r o w t h ,  d e v e l o p m e n t ,
differentiation, and metabolic processes. Many effects
of thyroid hormone occur at the level of gene expression
and are mediated by TRs. Multiple TR-encoding mRNA
exists in any given series (i.e. in any cell or tissue line),
and TRs are divided into α and β forms on the basis of
sequence similarities and chromosomal locations [1].
Three forms of human TR (hTR)-related cDNA have
been cloned: hTRα1, hTRα2, and hTRβ1 [2–4]. hTRβ2
is pituitary-specific. The genes for hTRα1 and hTRα2
are located on chromosome 17, while that for hTRβ1 is
on chromosome 3 [5,6]. Some authors report that
structural differences between α and β TRs can result
in different target gene specifications [7,8].
The role of TRs in human neoplastic transformation
is still unknown. To evaluate the potential contribution
of TRs to the pathogenesis of intracranial meningiomas,
we used reverse transcription coupled to the
polymerase chain reaction (RT-PCR) to investigate the
expression of TRs in human intracranial meningiomas,
and correlated the results with their clinical behavior.
MATERIALS AND METHODS
Intracranial meningioma specimens were used to
examine TR gene expression. TR mRNA levels were
determined using RT-PCR. hTRα1 cDNA is 1.2 kb,
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hTRα2 cDNA is 1.5 kb and hTRβ1 cDNA is 1.4 kb, as
previously described [9].
Tumor tissue
Patients in our hospital diagnosed with intracranial
meningioma using magnetic resonance imaging (MRI)
in the last 3 years underwent craniotomy to remove
the tumor. Tumor tissue was collected during surgery
and a portion was fixed with 10% formaldehyde and
embedded in paraffin for histopathologic verification.
RNA isolation
All reagents used for RNA isolation were molecular
biology reagents from Sigma Chemicals Co. (St. Louis,
MO, USA). Total RNA was prepared from each tumor
specimen by the guanidinium thiocyanate method,




RT of RNA followed by PCR was carried out as
described by Cook et al [11]. Briefly, 1 µg of total RNA
was incubated with 0.5 µg of oligo(dt) 90, 1 mM
deoxyribonucleoside triphosphates (dNTPs), 10 units
RNase inhibitor, and 10 units avian myeloblastosis
virus reverse transcriptase in 20 µL of 0.1 M Tris-HCl
buffer pH 8.3 containing 50 mM KCl, 10 mM MgCl2,
and 4 mM dithiothreitol.
The cDNA products of RT were used as templates
for PCR, which was carried out in 10 mM Tris-HCl/
pH 8.3, 50 mM KCl, 1.5 mM MgCl2, 0.1 mM dNTPs,
with 0.1 µg of the appropriate 5’ and 3’ primers and
0.5 units of Taq polymerase (5,000 units/mL). We
used the expression of glyceraldehyde-3-phosphate
dehydrogenase as an internal control.
The primers used to specifically amplify each of the
three  TR- isoforms were  as  fo l lows:  hTRα1 :
5 ’ - A T G G A A C A G A A G C C A A G C A A  a n d
3 ’ - T T A G A C T T C C T G A T C C T C A A ;  h T Rα 2 :
5 ’ - A T G G A A C A G A A G C C A A G C A A  a n d
3’-TCAGGGAGAGGCTGCATTGC; and hTRβ1:
5 ’ - A T G A C A G A A A A T G G C C T T A C  a n d
3’-CTAATCCTCGAACACTTCCA.
cDNAs were amplified using 34 cycles of PCR.
Each cycle consisted of denaturation at 94°C for 1
minute, annealing at 54°C for 2 minutes, and extension
at 72°C for 2 minutes. After amplification, the products
were examined by agarose gel electrophoresis and
amplified fragments were visualized using ethidium
bromide staining.
Southern hybridization
We used Southern blotting to identify the bands, as
previously described [12]. PCR products were blotted
by capillary transfer onto nitrocellulose membrane
and hybridized with the isoform-specific probes.
RESULTS
In this series, 25 cases of intracranial meningioma
were confirmed by histopathology and included 16
meningotheliomatous cases, two cases of transitional
type, three cases of atypical type, and four cases of
recurrent meningioma (of which two were atypical,
one was transitional, and one was meningiomatous).
Patient age ranged from 40 to 80 years (mean, 62
years), while tumor diameters ranged from 2 to 12 cm.
TR expression in the different types of meningiomas is
shown in the Table.
The expression of TRs is selectively active or inactive
in different types of intracranial meningiomas. hTRα1
was expressed in nine cases, hTRα2 was expressed in
14 cases, and both hTRα1 and hTRα2 were expressed
in five cases. hTRβ1 was selectively active in nine
cases of recurrent or malignant meningioma.
These results demonstrated, for the first time, that
the presence of a meningioma-specific form of TR
could be important for the prognosis of human
intracranial meningiomas, and was correlated with
clinical behavior.
DISCUSSION
Thyroid hormone has a unique function in the human
body. It is important for all human tissues and has
profound effects on metabolic rate and oxygen
consumption. Many effects of thyroid hormone in
human tissues are mediated through binding to TRs
and are related to the c-erb-A oncogene family. The
existence of several receptor isoforms suggests that
different functions are mediated by specific isoforms
and raises the possibility of functional differences.
TRs are derived from two genes [6]. hTRα is 86%
identical to hTRβ in the DNA- and T3-binding domains.
Each gene gives two isoforms (hTRα1, hTRα2, and
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hTRβ1, hTRβ2) due to alternative splicing of the
primary transcripts [6]. hTRα and hTRβ isoforms are
products of two distinct genes, while the β1 and β2
isoforms are splice variants of the same genes. hTRα1
mRNA is down-regulated by T3 in multiple tissues
including heart, kidney, and pituitary, but not in brain
[9]. hTRα1 and hTRβ1 are widely expressed, whereas the
hTRβ2 isoform is mainly limited to the pituitary [11].
The pathophysiologic state of malignancy involves
al terat ions in  normal  cel l  prol i ferat ion and
differentiation, and specific genetic sequences
(oncogenes) are implicated in the genesis of the
phenotype. The appropriate expression of oncogenes
appears to involve cell proliferation, differentiation,
and metabolic regulation, while inappropriate
expression leads to malignant phenotypes. Some
actions of thyroid hormone and cellular oncogenes
appear similar and interrelated, suggesting that thyroid
hormone may influence carcinogenesis.
To define the role of TRs in human tumorigenesis,
we previously characterized TRs in human pituitary
tumor cells and found that hTRβ1 is over-expressed in
invasive human pituitary tumor cells [13]. Other
authors have characterized TRs in hepatoma cell lines
[14,15]. The degree of differentiation was found to be
inversely correlated with the levels of hTRβ1. Tumors
with invasive potential have high levels of hTRβ1, and
cells are poorly differentiated. Cells with low levels of
hTRβ1 are well differentiated [15].
Meningiomas are common intracranial neoplasms.
They are typically benign, although the high recurrence
rate, incidence of growth at inoperable sites, and
perineural growth complicate surgical interventions.
Recently, characterization and identification of genes
differentially expressed in human meningiomas have
been observed and reported.
In the present  s tudy,  human intracranial
meningiomas shown to be recurrent, invasive, or with
malignant potential  by both imaging studies
( c o m p u t e r i z e d  t o m o g r a p h y  a n d  M R I )  a n d
histopathology were found to have hTRβ1 over-
expression (Table; Cases 1–4). This finding is
compatible with characteristics of both pituitary tumors
and hepatoma cell lines, and may be an indicator for
tumor recurrence or malignant transformation.
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